Comparing the Effect of drug Magnesium Sulphate with Bupivacaine versus Dexmedetomidine with Bupivacaine versus plain Bupivacaine in nerve block to relive postoperative pain in LSCS patients. The main outcome of the study is to compare the duration and effect of pain relief.

Comparing the effect of Magnesium sulphate with Bupivacaine versus Dexmedetomidine with Bupivacaine versus plain Bupivacaine in Transversus Abdominis Plain block for post operative analgesia in patient undergoing Elective Lower Segment Caesarean section - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084622

Enrollment

Registered

2025-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Transverse abdominis plane block: transverse abdominis plane block as an post operative analgesic agent for patients undergoing elective lscs Control Intervention1: transverse abdominis

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing Elective LSCS

Exclusion criteria

Exclusion criteria: Patients Already On Magnesium Sulphate therapy Patients With Coagulation Abnormality Patients with infection at Injection site

Design outcomes

Primary

Measure	Time frame
To compare the duration of analgesic effect to compare the VAS scoreTimepoint: at 4 hours, 8 hours, 12 hours, 16th hour , 20 and 24	—

Secondary

Measure	Time frame
Requirement of rescue analgesia for 24 hours post blockadeTimepoint: at 4 hours, 8 hours, 12 hours, 16th hour , 20 and 24	—

Countries

India

Contacts

Public ContactDr keerthiga M

Bhaarath medical college

keerthigamohan3@gmail.com9600506041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026